Actively Recruiting

Age: 0Years - 99Years
All Genders
ID06399952

A Prospective, Longitudinal and Observational Natural History Study for Children and Adults With Baker Gordon Syndrome - Genetic Autism Alliance

Led by University of Missouri-Columbia · Updated on 2026-06-03

50

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are conducting a prospective, longitudinal natural history study to understand the clinical progression of children and adults with Synaptotagmin1-Associated Neurodevelopmental Disorder, also known as Baker Gordon Syndrome (BAGOS). The study aims to develop effective outcome measures and diagnostic tools to prepare for future clinical trials, focusing on demographic, genetic, environmental factors, treatments, and medications linked to the disorder's development and outcomes. Participants will undergo various assessments including standard scales and questionnaires to evaluate global development, language, memory, and motor functions. They will keep sleep and seizure diaries, provide a small blood sample for whole genome sequencing and proteomic analysis, and have brain imaging via MRI and electroencephalography (EEG) to identify disease biomarkers. A small skin sample will be collected to develop patient-specific stem cells for further research on the impact of Synaptotagmin1 mutations. During the 24-month study, participants and their caregivers will be assessed using neurological and disability evaluation scales, behavior assessments, and other developmental tests. Researchers will collect medical data, monitor motor milestones, and evaluate sleep and attention. Caregivers and legal representatives will also participate by completing questionnaires and consenting to study procedures. The goal is to enhance understanding of BAGOS and prepare the healthcare system for future treatments.

CONDITIONS

Brief Title

Baker Gordon Syndrome Natural History Study

Who Can Participate

Age: 0Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Genetically confirmed diagnosis of Baker Gordon syndrome
  • Age between 0 and 99 years
  • Ability to send medical records and diagnostic test results
  • Ability to complete tests and questionnaires
  • Legal caregivers or legally authorized representatives must be 18 years or older
  • Willingness to follow study procedures and sign consent form
  • Ability to understand study information as assessed by the research team
Not Eligible

You will not qualify if you...

  • Presence of another condition unrelated to Baker Gordon syndrome that affects neurodevelopment
  • Caregivers or legally authorized representatives younger than 18 years old

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Initial visit

Participants undergo brain MRI, EEG recordings, blood collection for whole genome sequencing and proteomic analysis, and a skin punch biopsy to collect samples for research and biomarker identification.

1 visit (in-person)

Long-term Monitoring

Duration - 24 months

Participants are assessed over time using standard scales and questionnaires related to development, behavior, motor function, and sleep, while medical data is collected retrospectively and prospectively to understand the natural history of Baker Gordon Syndrome.

Multiple visits over 24 months

Trial Site Locations

Total: 1 location

1

University of Missouri Columbia

Columbia, Missouri, United States, 65201

Actively Recruiting

Loading map...

Research Team

W

W. David R Arnold, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A Center Based Early Intervention Program For Preschoolers W...

Development Disorder, Child

Actively Recruiting

1 location

A Multi-Site Leukopak Repository Providing Annotated Biospec...

Rare Diseases

Actively Recruiting

1 location

A Prospective Study to Evaluate the WatchPAT in Comparison t...

Sleep Disorder

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial